DE69710208D1 - Aktivatoren des cfrt-kanals und sie enthaltende pharmazeutische zusammensetzungen - Google Patents
Aktivatoren des cfrt-kanals und sie enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- DE69710208D1 DE69710208D1 DE69710208T DE69710208T DE69710208D1 DE 69710208 D1 DE69710208 D1 DE 69710208D1 DE 69710208 T DE69710208 T DE 69710208T DE 69710208 T DE69710208 T DE 69710208T DE 69710208 D1 DE69710208 D1 DE 69710208D1
- Authority
- DE
- Germany
- Prior art keywords
- cfrt
- pharmaceutical compositions
- compositions containing
- channel activators
- activators
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000012190 activator Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9609721A FR2751969B1 (fr) | 1996-08-01 | 1996-08-01 | Composes activateurs du canal cftr, et compositions pharmaceutiques les contenant |
PCT/FR1997/001436 WO1998005642A1 (fr) | 1996-08-01 | 1997-07-31 | Composes activateurs du canal cftr, et compositions pharmaceutiques les contenant |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69710208D1 true DE69710208D1 (de) | 2002-03-14 |
DE69710208T2 DE69710208T2 (de) | 2002-07-18 |
Family
ID=9494728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69710208T Expired - Lifetime DE69710208T2 (de) | 1996-08-01 | 1997-07-31 | Aktivatoren des cfrt-kanals und sie enthaltende pharmazeutische zusammensetzungen |
Country Status (7)
Country | Link |
---|---|
US (1) | US6630482B1 (de) |
EP (1) | EP0937044B1 (de) |
JP (1) | JP4376971B2 (de) |
CA (1) | CA2258924C (de) |
DE (1) | DE69710208T2 (de) |
FR (1) | FR2751969B1 (de) |
WO (1) | WO1998005642A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2840610B1 (fr) * | 2002-06-05 | 2008-04-04 | Centre Nat Rech Scient | UTILISATION DE DERIVES DES BENZO[c]QUINOLIZINIUMS POUR LE TRAITEMENT DES PATHOLOGIES LIEES AUX PHENOMENES DE CONSTRICTION DES CELLULES MUSCULAIRES LISSES |
FR2856926B1 (fr) | 2003-07-02 | 2005-09-30 | Centre Nat Rech Scient | Utilisation des n-alkanols comme activateurs du canal cftr |
CN1925854A (zh) * | 2003-11-14 | 2007-03-07 | 沃泰克斯药物股份有限公司 | 可用作atp-结合弹夹转运蛋白调控剂的噻唑和噁唑 |
EP1865949B1 (de) * | 2005-03-11 | 2012-11-14 | Vertex Pharmaceuticals Incorporated | Modulatoren von ATP-bindenden Kassettentransportern |
US8283351B2 (en) * | 2007-04-02 | 2012-10-09 | Institute For Oneworld Health | Cyclic and acyclic hydrazine derivatives compositions including them and uses thereof |
WO2009131947A2 (en) * | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, compositions and methods comprising pyridazine derivatives |
WO2009131951A2 (en) * | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, compositions and methods comprising isoxazole derivatives |
US8207205B2 (en) | 2008-04-21 | 2012-06-26 | Institute For Oneworld Health | Compounds, compositions and methods comprising oxadiazole derivatives |
US20090264433A1 (en) * | 2008-04-21 | 2009-10-22 | Institute For Oneworld Health | Compounds, Compositions and Methods Comprising Triazine Derivatives |
WO2010033626A1 (en) * | 2008-09-19 | 2010-03-25 | Institute For Oneworld Health | Compounds, compositions and methods comprising imidazole and triazole derivatives |
US8511216B2 (en) * | 2009-03-30 | 2013-08-20 | Kanzaki Kokyukoki Mfg. Co., Ltd. | Hydraulic actuator unit |
US8343976B2 (en) * | 2009-04-20 | 2013-01-01 | Institute For Oneworld Health | Compounds, compositions and methods comprising pyrazole derivatives |
WO2011019737A1 (en) | 2009-08-10 | 2011-02-17 | The Regents Of The University Of California | Pyrimido-pyrrolo-quinoxalinedione inhibitors of cystic fibrosis transmembrane conductance regulator protein and uses therefor |
USRE48842E1 (en) | 2011-05-27 | 2021-12-07 | The Regents Of The University Of California | Pyrimido-pyrrolo-oxazine-dione compound inhibitors of the cystic fibrosis transmembrane conductance regulator protein and uses therefor |
IL277071B1 (en) | 2018-03-08 | 2024-03-01 | Incyte Corp | Aminopyrizine diol compounds as PI3K–y inhibitors |
JP2021528480A (ja) | 2018-03-31 | 2021-10-21 | モレキュラー インターナショナル リサーチ, インコーポレーテッドMolecular International Research, Inc. | 予防及び治療に有効な選択的抗がん剤 |
US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
US20210386707A1 (en) * | 2018-10-30 | 2021-12-16 | New Mexico Tech University Research Park Corporation | Small molecules with anti-protozoan activity |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3320269A (en) * | 1963-07-19 | 1967-05-16 | Parke Davis & Co | beta-amino-alpha-phenoxy-2-stilbazole derivatives |
US3306896A (en) * | 1963-10-10 | 1967-02-28 | Parke Davis & Co | Amino derivatives of 2-stilbazole |
US3462446A (en) * | 1966-11-25 | 1969-08-19 | Parke Davis & Co | Substituted beta-amino-2-stilbazole compounds |
FI770346A (de) * | 1976-02-27 | 1977-08-28 | Ciba Geigy Ag | |
DE3027619A1 (de) * | 1979-07-25 | 1981-02-19 | Sandoz Ag | 6-alkyl-7-phenyl-1,6-naphtyradin- 5(6h)-on-derivate |
US4329349A (en) * | 1979-07-25 | 1982-05-11 | Sandoz, Inc. | 6-C1-4 Alkyl-7-phenyl or substituted phenyl-1,6-naphthyridine-5(6H)-ones |
ATE84533T1 (de) * | 1985-12-13 | 1993-01-15 | American Cyanamid Co | Neue kondensierte pyridinverbindungen, zwischenverbindungen fuer die herstellung und ihre verwendung als herbizide wirkstoffe. |
DK0480717T3 (da) * | 1990-10-12 | 1999-02-08 | Merck Frosst Canada Inc | Umættede hydroxyalkylquinolinsyrer som leukotrienantagonister |
GB9216768D0 (en) * | 1992-08-07 | 1992-09-23 | Leo Pharm Prod Ltd | Chemical compounds |
US5877179A (en) * | 1992-09-29 | 1999-03-02 | The United States Of America As Represented By The Department Of Health And Human Services | Xanthines for identifying CFTR--binding compounds useful for activating chloride conductance in animal cells |
JPH08198875A (ja) * | 1995-01-27 | 1996-08-06 | Chugai Pharmaceut Co Ltd | インドリジノン誘導体 |
-
1996
- 1996-08-01 FR FR9609721A patent/FR2751969B1/fr not_active Expired - Lifetime
-
1997
- 1997-07-31 JP JP50767798A patent/JP4376971B2/ja not_active Expired - Fee Related
- 1997-07-31 CA CA002258924A patent/CA2258924C/fr not_active Expired - Fee Related
- 1997-07-31 DE DE69710208T patent/DE69710208T2/de not_active Expired - Lifetime
- 1997-07-31 US US09/230,747 patent/US6630482B1/en not_active Expired - Lifetime
- 1997-07-31 EP EP97936724A patent/EP0937044B1/de not_active Expired - Lifetime
- 1997-07-31 WO PCT/FR1997/001436 patent/WO1998005642A1/fr active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CA2258924A1 (fr) | 1998-02-12 |
WO1998005642A1 (fr) | 1998-02-12 |
FR2751969A1 (fr) | 1998-02-06 |
EP0937044A1 (de) | 1999-08-25 |
JP4376971B2 (ja) | 2009-12-02 |
FR2751969B1 (fr) | 1998-12-04 |
CA2258924C (fr) | 2009-10-06 |
US6630482B1 (en) | 2003-10-07 |
EP0937044B1 (de) | 2002-01-30 |
DE69710208T2 (de) | 2002-07-18 |
JP2000515863A (ja) | 2000-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69710208T2 (de) | Aktivatoren des cfrt-kanals und sie enthaltende pharmazeutische zusammensetzungen | |
IL120141A0 (en) | Substituted quinazoline derivatives and pharmaceutical compositions containing them | |
IL131319A0 (en) | 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same | |
AU2137497A (en) | Taxoid anti-tumor agents and pharmaceutical compositions thereof | |
DE69618587D1 (de) | Chinazoline und pharmazeutische zusammensetzungen | |
HUP9900424A2 (hu) | Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények | |
HUP0004398A3 (en) | Alpha-aryl-n-alkylnitrones and pharmaceutical compositions containing the same | |
HUP0001309A3 (en) | 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them | |
DE69723398T2 (de) | Polyalkylphenoxyaminoalkane und diese enthaltende freibstoffzusammensetzungen | |
IL133097A0 (en) | Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof | |
HUP9904694A3 (en) | Spiropyrrolidine derivatives, their use and pharmaceutical compositions containing them | |
HUP0100470A3 (en) | Oxazolidinone derivatives and pharmaceutical compositions containing them | |
HUP9901452A3 (en) | Bicyclic-aromatic compounds and pharmaceutical compositions containing them | |
HU9800147D0 (en) | Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them | |
IL128058A0 (en) | Illudin analogs and pharmaceutical compositions containing the same | |
HUP9802132A3 (en) | Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them | |
HUP0100085A3 (en) | Biphenylamidine derivatives and pharmaceutical compositions containing them | |
IL134538A (en) | Lactacystin derivatives and pharmaceutical compositions containing the same | |
HUP0104852A3 (en) | Oktahydro-pyrido-pyrazine derivatives and pharmaceutical compositions containing the same and their use | |
HUP0101733A3 (en) | Pharmaceutical compositions containing sulfonyl-dipeptides and their use | |
DE69809928D1 (de) | Tizoxanide und nitazoxanide enthaltende pharmazeutische zusammensetzungen | |
HUP0000460A3 (en) | Imidazopyridazines and pharmaceutical compositions thereof | |
IL136045A0 (en) | Pyridylpyrrole derivatives and pharmaceutical compositions containing the same | |
HUP9802590A3 (en) | Indan-, benzothiophene-, benzofuran- and indolesulfonamide derivatives, their use and pharmaceutical compositions containing them | |
HUP0000966A3 (en) | Isoflavone derivatives and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |